Synopsis:
It is 15 years since the first Treat-to-Target recommendations in rheumatoid arthritis (RA) were published. In 2025, this treatment strategy for the management of RA is well accepted, but even in today’s clinic with multiple treatment options available, it is not routinely embedded into clinical practice. In this symposium, the presenters will discuss the value of embedding treat to target principles in today’s busy clinical practice which is often challenged by resource limitations. The presenters will share their perspectives on the opportunities that remain to be addressed and how technologic advances may help facilitate improvements in clinical care.
Practical tips that when implemented, even on a small scale, may improve patient outcomes will also be shared.
Agenda:
|
|
Chairperson: Tsutomu Takeuchi (竹内勤)
|
|
11:10-11:15 |
Introduction |
|
11:15-11:39 |
Patient-Centricity in Action: Navigating
complex RA with shared Decision
A/Prof Andrew Östör |
|
11:39-12:03 |
T2T revisited: here and beyond
Prof Kei Ikeda |
|
12:03-12:14 |
Bridging the gap: What we need to unleash the full potential of T2T |
|
12:14-12:15 |
Closing remarks |
